That Pier 1 Imports has filed for bankruptcy protection and put the company up for sale. How likely is the company to find a buyer?
With over 9,000 stores closed in the United States last year, the chance that a major retailer will die has escalated sharply. It will be worse this year than in 2019.
Bed Bath & Beyond is scheduled to release its fiscal second-quarter financial results after the markets close on Wednesday.
Bed Bath & Beyond is scheduled to release its most recent quarterly results later this week. One analyst is getting out ahead of the report and believes that it is this struggling retailer’s...
Pier 1 Imports stock sank after the specialty retailer reported its most recent quarterly results.
24/7 Wall St. has put together a preview of PepsiCo, Costco and some of the other companies that are about to report their quarterly results.
There may be retailers worst off than Pier 1 Imports, Inc (NYSE: PIR), but they can be counted on one hand. Very poor results knocked the stock to just above $1, down from a 52-week high of $5.92....
GTX, United Natural Foods, Pier 1 Imports, and PulteGroup all posted new 52-week lows Friday.
The top analyst upgrades, downgrades and initiations seen on Friday include AMD, Alcoa, AT&T, Darden Restaurants, Micron Technology, New Age Beverages, Nike, Novavax, Pier 1 Imports and Under...
The top analyst upgrades, downgrades and other research calls seen on Friday include Accenture, Ally, Diageo, Harley-Davidson, KB Home, NetApp, Nike, Sirius XM and Walgreens.
The the top analyst upgrades, downgrades and other research calls from Tuesday include ADT, CBOE, Celgene, JPMorgan, 3M, NetApp, Total, Tyson Foods and Weatherford.
24/7 Wall St. has put together a preview of Adobe, Costco, Oracle and some of the other top companies reporting their latest results in the coming week.
The top analyst upgrades, downgrades and other research calls include Archer Daniels Midland, BlackRock, DexCom, Mallinckrodt, McDonald's, Philip Morris and Redfin.
While investors love companies with high dividend yields and those that can be expected to raise dividends in the future, there is a dark side of dividend investing.
Shares of Pieris Pharmaceuticals saw perhaps one of the biggest gains on Wednesday after the company announced a critical collaboration with AstraZeneca.